Preeya Gupta, MD, & Cynthia Matossian, MD, FACS, ABES The journey of the dry eye patient can be challenging. They often go to multiple practitioners and try several at-home remedies in an attempt to have their condition taken seriously and get some relief. In this podcast, Cynthia Matossian, MD, FACS, ABES joins Preeya Gupta, MD to discuss the importance of building trust to empower dry eye patients to take back control in order to better manage their condition, as well as how EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25%*—the first FDA-approved steroid for the short-term treatment (up to two weeks) of the signs and symptoms of DED—and its AMPPLIFY® technology may benefit their patients.